M&As this week: JW Pharmaceutical, Lonza, Karo Intressenter
JW Pharmaceutical has acquired a 25% stake in Argonaut Therapeutics through a $2.6m investment.
Raghavi Joshi
Latest articles
All Articles
M&As this week: Strides Shasun, Takeda Pharmaceutical, Eli Lilly
Indian bio-pharmaceuticals developer Strides Shasun has signed an agreement with Apotex to merge with the latter’s Australian subsidiary, Apotex.
Deals this week: MannKind, XtalPi, Ascendia Pharmaceuticals
Indian biopharmaceutical company MannKind has agreed to sign a marketing and distribution agreement with Cipla for the inhaled insulin…
Deals this week: IntelGenx, Oasmia Pharmaceutical, Karo Pharma
Canadian oral drug delivery company IntelGenx Technologies plans to issue 300 units priced at $10,000 a unit in a…
M&As this week: United Therapeutics, Par Formulations, Endo Ventures
United Therapeutics Corporation has agreed to acquire SteadyMed for $216m.
Deals this week: CTD Holdings, Peptron, Hemispherx Biopharma
US-based biotechnology company CTD Holdings has completed issuing 20,000 units of series B convertible preferred stock for the development…
M&As this week: AstraZeneca, Mega Labs, Toho Holdings
AstraZeneca has agreed to purchase an additional 5.7% stake in Circassia Pharmaceuticals in a cash transaction.
Deals this week: Clovis Oncology, Les Laboratoires Servier, Bayer
US-based biopharmaceutical company Clovis Oncology has announced the pricing for its proposed issue of convertible senior notes due 1…
M&As this week: Wacker Biotech, Pacific Glory Development, Proteintech Group
Wacker Biotech has completed the acquisition of Synco Bio Partners, with the objective of expanding its portfolio and further…